Skip To Main Content
Neha Agarwal on Muck Rack

Neha Agarwal

As seen in: Medium, Nature, Wiley Online Library, Memory Studies, MDPI, Taylor & Francis Online, Agenda (World Economic Forum), Gartner, The Quint, DEV Community and

Get in touch with Neha

Contact Neha, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

From Handicrafts to High Fashion: Mapping India's Artistic Trade Footprint in the Global Luxury Economy

|
By Neha Agarwal
| ijfmr.com
India's rich heritage of handlooms and handicrafts has increasingly become a strategic asset in the global luxury fashion economy. This paper examines the growing collaboration between Indian artisans and international luxury brands, India's position in the global handicraft and textile export market, and the role of government schemes in supporting indigenous craftsmanship.
Open in Who Shared Issue with article?

Dashavatara: The Eternal Journey Of Dharma, Divine Purpose & Cosmic Balance

|
By Neha Agarwal, Arpita Anand
| thebusinessascent.com
The Dashavatara, the ten divine incarnations of Lord Vishnu, narrate the timeless journey of preserving dharma and restoring cosmic balance. Whenever evil threatens the world and righteousness declines, Vishnu manifests in different forms, each avatar embodying a unique purpose, virtue, and lesson for humanity. The story of the Dashavatara is not merely a sequence of divine incarnations but a profound exploration of human evolution, morality, and consciousness.
Open in Who Shared Issue with article?

Rutin-enabled Improved Systemic Exposure of Doxorubicin via Nanostructured Lipid Carriers: A proof of concept through novel LC-MS/MS analysis

|
By Neha Agarwal, Avijit Bakshi, Dilip Panwar
| Taylor & Francis Online
Abstract Objective The objective of this study was to develop and validate a sensitive LC–MS/MS method for simultaneous quantification of doxorubicin (DOX) and rutin (RUT) in plasma and to apply it as a proof-of-concept to investigate rutin-enabled enhancement of systemic DOX exposure via nanostructured lipid carriers (NLCs). Significance Poor oral bioavailability and dose-limiting toxicity restrict the clinical utility of DOX.
Open in Who Shared Issue with article?
See all 73 licensed articles (75 Total)